X
Record #70218

ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway

Publisher
Frontiers
Original paper date
Jan 23, 2020
Institution
Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China · Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China · Department of Pharmacognosy, School of Pharmacy, Second Military Medical University, Shanghai, China · School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China · Department of Drug Preparation, Hospital of TCM and Hui Nationality Medicine, Ningxia Medical University, Wuzhong, China · Department of Pharmacy, Yangpu Hospital, Tongji University School of Medicine, Shanghai, China · Central Laboratory, Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China · School of Pharmacy and Biomolecular Sciences, Faculty of Science, Liverpool John Moores University, Liverpool, United Kingdom
Open access
No
Article type
Research Article
Broad categories
(BLS) Biology - Cellular(BLS) Genetics(HSC) Medicine - Diabetes(HSC) Medicine - Pathology(HSC) Medicine - Pharmacology(HSC) Medicine - Urology/Nephrology
Notes from Retraction Watch

See also: https://pubpeer.com/publications/33D7B212B444024C81396DE190F6A1

Citation lifecycle

How this paper is being cited

Pre-retraction
5
Same day
0
Post-retraction
26
% post-retraction
83.9%
~2.8 citations/yr before retraction · ~5.4 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse